CBER Director Peter Marks (Jim Lo Scalzo/Pool via AP Images)
Marks: FDA open to using single-arm studies for accelerated approval of rare disease gene therapies
Peter Marks, the FDA official who oversees gene therapies, is again advocating for the use of accelerated approvals for gene therapies that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
